Serum ferritin in colorectal cancer patients and its prognostic evaluation

International Journal of Biological Markers

Volumn 21, Issue 4, 2006, Pages 235-241

  Lorenzi, Marco ^a   Lorenzi, B ^a   Vernillo, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Colorectal cancer; Prognosis; Serum ferritin

Indexed keywords

FERRITIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PREOPERATIVE EVALUATION; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL TIME;

EID: 33846589444     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.2954     Document Type: Article

References (31)

1. Burns ER, Goldberg SN, Lawrence C, Wenz B. Clinical utility of serum tests for iron deficiency in hospitalized patients. Am J Clin Pathol 1990; 93: 240-5.
2. Mansouri A, Lipschitz DA. Anemia in the elderly patient. Med Clin North Am 1992; 76: 619-30.
3. Harju E. Body iron stores in patients subjected to surgery of the large bowel. Dis Colon Rectum 1988; 31: 42-5.
4. Streiff RR. Anemia and nutritional deficiency in the acutely ill hospitalized patients. Med Clin North Am 1993; 77: 911-8.
5. Ljungberg B, Grankvist K, Rasmuson T. Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 1995; 76: 1435-9.
6. Milman N, Pedersen LM. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncol Rep 2002; 9: 193-8.
7. Miyata Y, Koga S, Nishikido M, et al. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology 2001; 58: 161-4.
8. Ozen H, Uygur C, Sahin A, Tekgul S, Ergen A, Remzi D. Clinical significance of serum ferritin in patients with renal cell carcinoma. Urology 1995; 46: 494-8.
9. Partin AW, Criley SR, Steiner MS, et al. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology 1995; 45: 211-7.
10. Rosati G, Riccardi F, Tucci A. Use of tumor markers in the management of head and neck cancer. Int J Biol Markers 2000; 15: 179-83.
11. Ulbrich EJ, Lebrecht A, Schneider I, Ludwig E, Koelbl H, Hefler LA. Serum parameters of iron metabolism in patients with breast cancer. Anticancer Res 2003; 23: 5107-9.
12. Beale AL, Penney MD, Allison MC. The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis 2005; 7: 398-402.
13. Kishida T, Sato J, Fujimori S, et al. Clinical significance of serum iron and ferritin in patients with colorectal cancer. J Gastroenterol 1994; 29: 19-23.
14. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S. Iron concentrations in intestinal cancer tissue and in colon and rectum polyps. Biol Trace Elem Res 2003; 95: 19-28.
15. Li F, Kishida T, Kobayashi M. Serum iron and ferritin levels in patients with colorectal cancer in relation to the size, site, and disease stage of cancer. J Gastroenterol 1999; 34: 195-9.
16. Dukes CE. The classification of cancer of the rectum. J Path Bacteriol 1932; 35: 323-32.
17. Turnbull RB Jr, Kyle K, Watson FB, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 1967: 166: 420-7.
18. Dixon WJ. BMDP-Biomedical Computer Programs. Statistical Software. Berkeley, CA: University of California Press, 1992.
19. Bird CL, Witte JS, Swendseid ME, et al. Plasma ferritin, iron intake, and risk of colorectal polyps. Am J Epidemiol 1996; 144: 34-41.
20. Kato I, Dnistrian AM, Schwartz M, et al. Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int J Cancer 1999; 80: 693-8.
21. Nelson RL. Iron and colorectal cancer risk: human studies. Nutr Rev 2001; 59: 140-8.
22. Tseng M, Greenberg ER, Sandler RS, et al. Serum ferritin concentration and recurrence of colorectal adenoma. Cancer Epidemiol Biomark Prev 2000; 9: 625-30
23. Hsu PI, Chow NH, Lin XZ, Yang HB, Chan SH, Lee PC. Prognostic significance of ferritin expression in colorectal adenocarcinoma. Anticancer Res 1995; 15: 1087-93.
24. Yang HB, Hsu PI, Lee JC, Chan SH, Lin XZ, Chow NH. Adenoma-carcinoma sequence: a reappraisal with immunohistochemical expression of ferritin. J Surg Oncol 1995; 60: 35-40.
25. Lee JG, Sahagun G, Oehlke MA, Lieberman DA. Serious gastrointestinal pathology found in patients with serum ferritin values < or = 50 ng /ml. Am J Gastroenterol 1998; 93: 772-6.
26. McIntyre AS, Long RG. Prospective survey of investigations in outpatients referred with iron deficiency anaemia. Gut 1993; 34: 1102-7.
27. Scholefield JH, Robinson MH, Bostock K, Brown NS. Serum ferritin. Screening test for colorectal cancer? Dis Colon Rectum 1998; 41: 1029-31.
28. Acher PL, Al-Mishlab T, Rahman M, Bates T. Iron-deficiency anaemia and delay in the diagnosis of colorectal cancer. Colorectal Dis 2003; 5: 145-8.
29. Sadahiro S, Suzuki T, Tokunaga N, et al. Anemia in patients with colorectal cancer. J Gastroenterol 1998; 33: 488-94.
30. Balan V, Baldus W, Fairbanks V, Michels V, Burrit M, Klee G. Screening for hemochromatosis: a cost effectiveness study based on 12,258 patients. Gastroenterology 1994; 107: 453-9.
31. Bjorklund B. On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagnostik 1980; 1: 9-20.